India hosts 2nd policymakers' forum to strengthen global collaboration on drug standards, access to affordable medicines
New Delhi [India], June 16 (ANI): The Second Policymakers' Forum, aimed at promoting the recognition of the Indian Pharmacopoeia, was inaugurated on Sunday at Sushma Swaraj Bhawan in the national capital.
The event was being organised by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, in association with the Ministry of External Affairs and in collaboration with India's flagship affordable medicines initiative--the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).
The inaugural session was graced by the presence of Minister of State for Health & Family Welfare and Chemicals & Fertilisers, Anupriya Patel, who delivered the keynote address and released a commemorative publication marking IPC's 15-year journey.
The gathering was also addressed by Secretary (South), Ministry of External Affairs, Neena Malhotra; Secretary, Health and Family Welfare, Punya Salila Srivastava; Drug Controller General of India and Secretary-cum-Scientific Director, IPC, Dr Rajeev Singh Raghuvanshi; and Advisor (Cost), Ministry of Health & Family Welfare, Rajiv Wadhawan.
In her keynote address, Patel emphasised India's commitment to ensuring equitable access to quality-assured medicines and stressed the importance of regulatory harmonisation in facilitating global health equity.
She also highlighted that under the visionary leadership of Prime Minister Narendra Modi, India has emerged as a global hub for affordable healthcare solutions and continues to deepen its partnerships with nations through knowledge-sharing, capacity-building, and health diplomacy.
The Forum has brought together policymakers and senior drug regulatory officials from 22 countries, including Liberia, Togo, Mali, Mauritania, Sierra Leone, Cameroon, Rwanda, Lesotho, Eswatini, Kenya, Botswana, Ethiopia, Comoros, Seychelles, Madagascar, Papua New Guinea, Zimbabwe, St Lucia, St Vincent & Grenadines, Cuba, Barbados, and Chile, along with two delegates from the Caribbean Public Health Agency (CARPHA), reaffirming India's position as a valued and trusted partner in the realm of global health.
This engagement builds on the momentum generated by the First Policymakers' Forum held in August 2024, which resulted in several participating countries formally recognising the Indian Pharmacopoeia as a book of standards for drugs.
The growing international interest in aligning with India's regulatory frameworks reflects the credibility and scientific rigour of the Indian Pharmacopoeia, as well as India's proactive role in advancing global public health objectives.
Over the course of the four-day programme from June 16 to June 19, delegates will participate in technical sessions covering pharmacopoeial standards, India's regulatory landscape, and successful public health schemes. The technical session on 16th June featured presentations by Dr Rajeev Singh Raghuvanshi, Drug Controller General of India and Secretary-cum-Scientific Director, IPC, on the role and progress of IPC; Dr Ranga Chandrasekhar, Joint Drugs Controller, on the regulatory mechanisms of the Central Drugs Standard Control Organisation; and Ravi Dadhich, CEO of Pharmaceuticals & Medical Devices Bureau of India, on the implementation and impact of PMBJP.
In addition, site visits to IPC's state-of-the-art laboratories in Ghaziabad and a Janaushadhi Kendra in Agra, as well as leading pharmaceutical and vaccine manufacturing and R&D facilities in Ahmedabad, have been arranged to provide delegates with first-hand exposure to India's robust scientific and regulatory systems.
The Second Policymakers' Forum stands as a platform for building mutual trust, regulatory convergence, and long-term collaboration toward the shared objective of 'Health for All'. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Gazette
4 hours ago
- India Gazette
"Historic step": Union Minister Kishan Reddy lauds centre's decision to conduct caste census
Hyderabad (Telangana) [India], June 17 (ANI): Union Minister G Kishan Reddy on Monday lauded the centre's decision to conduct the 16th population census, which would include caste enumeration, and labelled it a 'historic step.' Advocating for the caste census, he said that the work at the policy level with regard to the welfare schemes, budget allocation, political reservations would be worked upon in a proper manner. 'The government of India has taken a historic step. Since Independence, the general census will entail a census of the backward classes. Today, the government of India has issued the notification. There will also be a caste census; it is a very big decision. After this, be it welfare activity, scheme, budget allocation, political reservation, everything will be worked upon in a proper manner,' Reddy told ANI. Speaking about the arrangements for the Covid-19 cases, Reddy said that he was visiting his Lok Sabha constituency (Secunderabad) and the hospitals here to inspect whether big hospitals have necessary arrangements for Covid cases. 'Recently, in a cabinet meeting, PM Modi directed all the ministers to visit big hospitals in their respective constituencies. It was to ensure that big hospitals had all the necessary arrangements for Covid this regard, today, I have come here to the Gandhi Hospital in my (Lok Sabha) constituency. The hospital's senior officials have assured me that the hospital is completely ready for the Covid patients,' the Union Minister said. On Monday, the central government notified the population census, the process of which will begin in March 2027. As per a gazette notification released by the Ministry of Home Affairs, 'In exercise of the powers conferred by Section three of the Census Act 1948 and in suppression of the notification of the Government of India in the Ministry of Home Affairs dated March 26, 2018, the Central Government declared that a census of the population of India shall be taken during the year 2027, as per a circular released by the Ministry of Home Affairs.' The reference date for the census shall be March 1, 2027, except for the Union territory of Ladakh and the snow-bound non-synchronous areas of the Union territory of Jammu and Kashmir and the states of Himachal Pradesh and Uttarakhand. Furthermore, the reference date for the Union Territory of Ladakh, snow-bound non-synchronous areas of the Union Territory of Jammu and Kashmir, and the states of Himachal Pradesh and Uttarakhand will be October 1, 2026. The Census will be conducted in two phases. In phase 1, House Listing Operation (HLO), the housing conditions, assets and amenities of each household will be collected. Subsequently, in the second phase, Population Enumeration (PE), the demographic, socio-economic, cultural and other details of every person in each household will be collected. Caste enumeration will also be done during the census. For Census activities, about 34 lakh enumerators and supervisors and around 1.3 lakh Census functionaries would be deployed. This is the 16th Census since its beginning and the 8th since independence. The ensuing Census will be conducted through digital means using mobile applications. Provision of Self-enumeration would also be made available to the people. Very stringent data security measures would be kept in place to ensure data security at the time of collection, transmission and storage. (ANI)
Hindustan Times
5 hours ago
- Hindustan Times
DNA verification completed for 119 victims in Air India plane crash
DNA tests have verified the identities of 119 victims who died on June 12 after an Air India flight AI1717 crashed in Ahmedabad shortly after take-off, reported ANI. Dr Rakesh Joshi, superintendent of the Ahmedabad Civil Hospital confirmed that efforts were still ongoing to identify the more than 270 victims of the plane crash. Also Read: New video shows lone survivor walking away as crashed plane turns into fireball Dr Joshi said, "We have matched DNA samples of 119 victims. Of these, 76 mortal remains have already been handed over to their respective families." He added, 'Out of the remaining 43, the mortal remains of 14 deceased will be handed over by tomorrow morning. As time is running, people are also going through panic. We are receiving panic calls. As we are matching DNAs, results will keep coming.' Also Read: Did double engine failure cause the Air India plane crash? PIB fact-checks The London-bound Boeing 787-8 Dreamliner aircraft crashed into a hostel complex shortly after takeoff from Sardar Vallabhbhai Patel International Airport on June 12, killing most of the passengers and crew, including former Gujarat Chief Minister Vijay Rupani. 241 out of the 242 passengers and crew on the flight died, while 29 ground victims were reported. There was only one survivor from the flight. Also Read: 'Asked to pay ₹1.1 lakh before flight': Air India crash victim's claims; MHA clarifies Of the 51 people injured in the incident, 38 have been discharged, while 13 are still undergoing treatment, said Dr. Patel, a professor of surgery at the government-run B J Medical College. The Gujarat state relief commissioner Alok Kumar Pandey told PTI that families of all 230 passengers who died on the flight had been contacted. "Members of only three deceased passengers are yet to give their DNA samples as they live abroad. They are expected to arrive tomorrow evening. Along with the mortal remains, we are also handing over death certificates to the kin so that they don't face any issues afterwards," said Pandey.
United News of India
5 hours ago
- United News of India
70 pc of the WHO's total vaccines are from India: Govt
New Delhi, June 16 (UNI) Reaffirming India's pivotal role in the global pharmaceutical industry, Minister of State for Health and Family Welfare, Anupriya Patel on Monday pointed out that 70 percent of the World Health Organisation's (WHO) total vaccines are sourced from India. She also highlighted that 14 percent of generics imported by the United States come from India, further showcasing India's dominance in the pharmaceutical sector. The Forum, organised by the Indian Pharmacopoeia Commission (IPC) under the Union Health Ministry, brings together an international delegation of policymakers, drug regulators, and experts from 24 countries including Liberia, Togo, Mali, and Papua New Guinea, among others. Patel also praised India's flagship initiative, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), which aims to provide affordable medicines to all citizens. She further noted that the Jan Aushadhi Kendras, which are integral to this program, serve as "shining examples of India's commitment to making quality medicines accessible to all." "These centres have proven to be vital in reducing out-of-pocket medical expenses for millions of Indians," Patel added, underscoring the importance of such initiatives in improving public health. 'As much as 70% of WHO's vaccines come from India…India is the world's top producer of generics, with 14% of the generics imported by the US sourced from India. We also have the highest number of US FDA-recognized drug manufacturing plants,' she said. Furthermore, Patel highlighted India's robust regulatory framework, noting that the country retains the WHO's Global Benchmarking Tool (GBT) Maturity Level 3 (ML3) status. This, she explained, reflects India's commitment to maintaining high standards in drug regulation. The Indian Pharmacopoeia, she added, is now recognised by 15 countries worldwide, with Cuba being the most recent to adopt it as a standard for drug quality. Union Health Secretary, Punya Salila Srivastava, also addressed the forum, pointing out that over 1.75 lakh Ayushman Arogya Mandirs (previously known as Health and Wellness Centres) have been established across India, where free drugs and diagnostics are provided to the public. She also discussed the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY), a health assurance scheme that offers up to ₹5 lakh coverage per family, benefiting 40% of India's population. The scheme has helped reduce out-of-pocket health expenditure from 70% in 2004 to just 40% today. UNI AJ SSP
